Related references
Note: Only part of the references are listed.Lower Malignancy Rates in Renal Allograft Recipients Converted to Sirolimus-Based, Calcineurin Inhibitor-Free Immunotherapy: 24-Month Results From the CONVERT Trial
Josefina Alberu et al.
TRANSPLANTATION (2011)
Switch to a Sirolimus-Based Immunosuppression in Long-Term Renal Transplant Recipients: Reduced Rate of (Pre-)Malignancies and Nonmelanoma Skin Cancer in a Prospective, Randomized, Assessor-Blinded, Controlled Clinical Trial
R. Salgo et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
The mTOR Pathway: A New Target in Cancer Therapy
L. Ciuffreda et al.
CURRENT CANCER DRUG TARGETS (2010)
Distinct Immunohistochemical Phenotype of Nonmelanoma Skin Cancers Between Renal Transplant and Immunocompetent Populations
Alex Gutierrez-Dalmau et al.
TRANSPLANTATION (2010)
Genus β human papillomaviruses and incidence of basal cell and squamous cell carcinomas of skin: population based case-control study
Margaret R. Karagas et al.
BRITISH MEDICAL JOURNAL (2010)
Conversion From Calcineurin Inhibitors to Sirolimus Maintenance Therapy in Renal Allograft Recipients: 24-Month Efficacy and Safety Results From the CONVERT Trial
Francesco P. Schena et al.
TRANSPLANTATION (2009)
Skin cancer in organ transplant recipients -: Where do we stand today?
C. Ulrich et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
The janus face of immunosuppression - de novo malignancy after renal transplantation: the experience of the Transplantation Center Munich
C. D. Wimmer et al.
KIDNEY INTERNATIONAL (2007)
Immunosuppressive therapy and malignancy in organ transplant recipients - A systematic review
Alex Gutierrez-Dalmau et al.
DRUGS (2007)
Conversion to sirolimus: A useful strategy for recalcitrant cutaneous viral warts in liver transplant recipient
Sebastien Dharancy et al.
LIVER TRANSPLANTATION (2006)
Post-transplant de novo malignancies in renal transplant recipients:: the past and present
H. Myron Kauffman et al.
TRANSPLANT INTERNATIONAL (2006)
Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation
Josep M. Campistol et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies
HM Kauffman et al.
TRANSPLANTATION (2005)
Rapamycin: An anti-cancer immunosuppressant?
BK Law
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2005)
Cancer incidence after immunosuppressive treatment following kidney transplantation
A Andrés
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2005)
Sirolimus for Kaposi's sarcoma in renal-transplant recipients
G Stallone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Guidelines for the management of squamous cell carcinoma in organ transplant recipients
T Stasko et al.
DERMATOLOGIC SURGERY (2004)
Conversion to sirolimus: A successful treatment for posttransplantation Kaposi's sarcoma
JM Campistol et al.
TRANSPLANTATION (2004)
Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: results from five multicenter studies
T Mathew et al.
CLINICAL TRANSPLANTATION (2004)
Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation
M Guba et al.
TRANSPLANTATION (2004)
Tacrolimus enhances transforming growth factor-β1 expression and promotes tumor progression
M Maluccio et al.
TRANSPLANTATION (2003)
Differential molecular profiling between skin carcinomas reveals four newly reported genes potentially implicated in squamous cell carcinoma development
C Marionnet et al.
ONCOGENE (2003)
Medical progress - Skin cancers after organ transplantation
S Euvrard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Incidence and prediction of nonmelanoma skin cancer post-renal transplantation: A prospective study in Queensland, Australia
RP Carroll et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2003)
Non-melanoma skin cancer risk in the Queensland renal transplant population
HM Ramsay et al.
BRITISH JOURNAL OF DERMATOLOGY (2002)
Rapamycin blocks tumor progression: Unlinking immunosuppression from antitumor efficacy
FL Luan et al.
TRANSPLANTATION (2002)
Incidence and clinical course of de-novo malignancies in renal allograft recipients
JT Winkelhorst et al.
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY (2001)
Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients
HM Ramsay et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2000)
Share Paper
